Kevin Moran serves as the Senior Vice President, Chief Financial Officer, and Treasurer at Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs. In his role, Moran is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, tax, and treasury functions. His strategic financial leadership has been instrumental in guiding Vanda Pharmaceuticals through various stages of growth and development. Before joining Vanda Pharmaceuticals, Moran held several senior financial positions at various organizations, showcasing his extensive experience in the biopharmaceutical industry. He previously served as the Chief Financial Officer at Hyperion Therapeutics, where he played a key role in the company's successful initial public offering and subsequent acquisition by Horizon Pharma. Moran also held financial leadership roles at McKesson Corporation and started his career at KPMG LLP, where he honed his skills in auditing and financial management. His diverse background has equipped him with the expertise needed to navigate complex financial landscapes and drive sustainable growth. Moran's achievements at Vanda Pharmaceuticals include strengthening the company's financial position and implementing robust financial strategies that support its long-term objectives. Under his leadership, Vanda has been able to successfully manage its resources to fund research and development initiatives, while also ensuring compliance with financial regulations and maintaining transparency with stakeholders. Moran's commitment to excellence and strategic vision continue to be vital assets for Vanda Pharmaceuticals as it strives to bring innovative treatments to patients worldwide.